Management of Leptospirosis
Treatment should be initiated immediately upon clinical suspicion with penicillin or tetracycline antibiotics during the bacteraemic phase, though severe disease with jaundice and organ failure may require intensive supportive care including renal and liver support, as severe disease is likely immunologically mediated and may not respond to antibiotics alone 1.
Antibiotic Therapy
First-Line Options
The guideline evidence supports several antibiotic choices for leptospirosis 1:
- Penicillin: Long considered the treatment of choice, effective during the bacteraemic phase
- Tetracycline antibiotics (including doxycycline): Equally effective as penicillin during early disease
- Cephalosporins (cefotaxime, ceftriaxone): Recent evidence supports these as acceptable and potentially preferred agents 2, 3
Recent network meta-analysis data demonstrates that cefotaxime showed the shortest defervescence time (MD -1.88 days), followed by azithromycin, doxycycline, ceftriaxone, and penicillin—all significantly better than no treatment 2. However, antibiotics did not reduce mortality or hospital stays in this analysis.
Practical Antibiotic Selection
For mild disease: Doxycycline or oral penicillin For severe disease (Weil's disease with jaundice): Intravenous ceftriaxone or cefotaxime may be preferred over penicillin 2, 3 Alternative option: Azithromycin appears promising for less severe disease 3
Critical Timing Consideration
Treatment must begin upon clinical suspicion given the non-specific nature of initial investigations 1. Waiting for serological confirmation (which takes 6-10 days to become positive) delays potentially beneficial therapy during the bacteraemic phase.
Supportive Care for Severe Disease
Patients with Weil's disease (jaundice, hemorrhage, hepatorenal failure) require aggressive organ support 1, 4:
- Renal replacement therapy: Initiated using standard indications for acute kidney injury (20% of ICU patients required this) 4
- Vasopressor support: Needed in 80% of critically ill patients 4
- Mechanical ventilation: Lung-protective ventilation strategy when required (27% of ICU patients) 4
- Fluid resuscitation: Conservative approach following contemporary sepsis principles 4
- Blood product transfusion: Restrictive strategy 4
Important Caveat About Severe Disease
A systematic review showed no benefit for antibiotic treatment in established severe leptospirosis based on three trials 1. However, most infectious disease specialists continue recommending antibiotics, acknowledging that severe disease is probably immunologically mediated rather than directly bacterial. The excellent outcomes (100% survival in 60 consecutive ICU patients) achieved with standard sepsis management principles suggest that high-quality supportive care is paramount 4.
Corticosteroid Therapy
The role of corticosteroids remains controversial and not routinely recommended 1. The guideline mentions short-course hydrocortisone for blood pressure support (used in 38% of ICU patients) 4, but this is for hemodynamic support rather than disease-specific therapy. One recent case report showed dramatic improvement with methylprednisolone in severe disease 5, but this requires further validation before routine use can be recommended.
Clinical Monitoring
Key Laboratory Findings to Track
- Urinalysis: Proteinuria and hematuria are common
- Complete blood count: Watch for thrombocytopenia, anemia from hemorrhage, polymorphonuclear leukocytosis
- Renal function: Biochemical evidence of renal failure
- Liver function: High bilirubin with mild transaminase elevation (distinguishes from viral hepatitis)
- Coagulation: Often normal despite bleeding (due to capillary fragility rather than coagulopathy) 1
Diagnostic Confirmation
- Serology: IgM titer >1:320 is suggestive; 1:80-1:160 consistent with early infection but may represent cross-reactions
- Convalescent serology: Obtain >10 days after symptom onset for IgM ELISA and microscopic agglutination test (MAT)
- Blood cultures: Take within first 5 days before antibiotics, keep at room temperature
- Note: Urine is NOT suitable for Leptospira isolation 1
Common Pitfalls
- Delaying treatment while awaiting diagnostic confirmation—treat empirically based on clinical suspicion and exposure history
- Expecting antibiotics to reverse severe organ dysfunction—the immune phase is immunologically mediated and requires primarily supportive care
- Overlooking the biphasic nature: Initial flu-like illness (4-7 days) followed by immune phase (1-3 days later) with hepatorenal syndrome
- Missing the diagnostic clue of conjunctival suffusion with calf myalgia in a patient with freshwater exposure 1